Immunitor's Breakthrough In Cancer Immunotherapy
6/25/2014 8:11:11 AM
VANCOUVER, British Columbia, June 25, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Immunitor Inc., a Vancouver-based biopharmaceutical company engaged in the discovery and development of oral vaccines, announced today that initial clinical data of the company's lead cancer vaccine has been presented as an oral presentation at the 4th International Conference "Current Advances in Microbiology and Immunology", held in Ulaanbaatar, Mongolia. Presentation dealt with findings from the proof-of-concept study in thirteen patients diagnosed with advanced hepatocellular carcinoma (HCC) or liver cancer.
Help employers find you! Check out all the jobs and post your resume.
comments powered by